Skip to main content
SpringerLink
Log in

Atracurium and laudanosine pharmacokinetics in acute renal failure

  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stenlake JD, Waigh RD, Urwin J, Dewar GH, Coker GG (1983) Atracurium: conception and inception. Br J Anaesth 55:3S-10S

    Google Scholar 

  2. Ward S, Boheimer N, Weatherley BC, Simmonds RJ, Dopson TA (1987) Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients with renal failure. Br J Anaesth 59:697–706

    Google Scholar 

  3. Hunter JM, Jones RS, Utting JE (1984) Comparison of vecuronium, atracurium and tubocurarine in normal patiens and in patients with no renal function. Br J Anaesth 56:941–951

    Google Scholar 

  4. Bell CF, Hunter JM, Jones RS, Utting JE (1985) Use of atracurium in patients with oesophageal varices. Br J Anaesth 57:160–168

    Google Scholar 

  5. Fahey MR, Rupp SM, Fisher DM et al (1984) The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure Anesthesiology 61:699–702

    Google Scholar 

  6. Wadon AJ, Dogra S, Anand S (1986) Atracurium infusion in the intensive care unit. Br J Anaesth 58:64S-67S

    Google Scholar 

  7. Griffiths RB, Hunter JM, Jones RS (1986) Atracurium, infusions in patients with renal failure on an ITU. Anaesthesia 47:375–381

    Google Scholar 

  8. Yate PM, Flynn PJ, Arnold RW et al (1987) Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive care unit. Br J Anaesth 59:211–217

    Google Scholar 

  9. Parker CJR, Jones JE, Hunter JM (1988) Desposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU Br J Anaestl 61:531–540

    Google Scholar 

  10. Shearer ES, O'Sullivan EP, Hunter JM (1991) Clearance of atracurium and laudanosine in the urine and by continuous verovenous haemofiltration. Br J Anaesth 67:569–573

    Google Scholar 

  11. Vandenbrom RHG, Wierda JMKH, Agoston S (1991) Pharmacokinetics and neuromuscular effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet 19:230–240

    Google Scholar 

  12. Neill EAM, Chapple DJ (1982) Metabolic studies in the cat with atracurium: A neuromuscular blocking agent designed for non-enzymatic inactivation at physiological pH. Xenobiotica 12:203–210

    Google Scholar 

  13. Sweny P (1991) Haemofiltration and haemodiafiltration-theoretical and practical aspects. Curr Anaesth Crit Care 2:37–43

    Google Scholar 

  14. Keller F, Wilms H, Schultze G, Offerman G, Molzahn M (1983) Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by haemodialysis. Clin Nephrol 19:201–205

    Google Scholar 

  15. Hunter JM (1991) Resistance to non-depolarising muscle relaxants. Br J Anaesth 67:511–514

    Google Scholar 

  16. Golper TA, Pullian J, Bennett WM (1985) Removal of therapeutic drugs by continuous arteriovenous hemofiltration. Arch Intern Med 145:1651–1652

    Google Scholar 

  17. Cozanitis D, Haapanen E (1979) Studies on muscle relaxants during haemccialysis. Acta Anaesthesiol Scand 23:225–234

    Google Scholar 

  18. Chapple DJ, Miller AA, Ward JB, Wheatley PL (1987) Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetised dogs. Br J Anaesth 59:218–225

    Google Scholar 

  19. Ingram MD, Sclabassi RJ, Stiller RL, Cook DR, Bennett MH (1985) Cardiovascular and electroencephalographic effects of laudanosine in “nephrectomised” cats. Anesth Analg 64:232

    Google Scholar 

  20. Fahey MR, Rupp SM, Canfell C, Fisher DM, Miller RD, Sharma M, Castognoli K, Hennis PJ (1985) Effect of renal failure on laudanosine excretion in man. Br J Anaesth 57:1049–1051

    Google Scholar 

  21. Smith CL, Hunter JM, Jones RS (1987) Prolonged paralysis following an infusion of alcuronium in a patient with renal dysfunction. Anaesthesia 42:522–525

    Google Scholar 

  22. Gwinnutt CL, Eddleston JM, Edwards D, Pollard BJ (1990) Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth 65:829–832

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Department of Anaesthesia, Royal Liverpool University Hospital, P.O. Box 147, L69 3BX, Liverpool, UK

    J. M. Hunter

Authors
  1. J. M. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hunter, J.M. Atracurium and laudanosine pharmacokinetics in acute renal failure. Intensive Care Med 19 (Suppl 2), S91–S93 (1993). https://doi.org/10.1007/BF01708808

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01708808

Keywords

Search

Navigation